The Effects of Topical Calcium Glycerophosphate on Surgical Wound Healing and Residual Scarring
NCT ID: NCT01264588
Last Updated: 2010-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2008-04-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
topical calcium glycerophosphate lotion
Topical calcium glycerophosphate lotion
2g once daily for 6 weeks (post-op day 3 thru 42)
standard-of-care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topical calcium glycerophosphate lotion
2g once daily for 6 weeks (post-op day 3 thru 42)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 45-75 years of age
* Scheduled for bilateral knee replacement surgery
Exclusion Criteria
* Pregnant or breast feeding Known allergy or hypersensitivity to calcium or phosphorus supplements
* Diagnosed with type I or type II diabetes mellitus
45 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rothman Institute Orthopaedics
OTHER
Texas Tech University Health Sciences Center
OTHER
Cyberderm Inc.
INDUSTRY
Bacharach Institute for Rehabilitation, Pomona, NJ
OTHER
AkPharma Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rothman Institute Orthopaedics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alvin C. Ong, M.D.
Role: PRINCIPAL_INVESTIGATOR
Rothman Institute Orthopaedics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rothman Institute Orthopaedics
Egg Harbor, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TOPCGP-2008
Identifier Type: -
Identifier Source: org_study_id